RTX3B_ACTPL
ID RTX3B_ACTPL Reviewed; 711 AA.
AC Q04473;
DT 01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT 01-NOV-1995, sequence version 1.
DT 03-AUG-2022, entry version 121.
DE RecName: Full=Toxin RTX-III translocation ATP-binding protein;
DE AltName: Full=APX-IIIB;
DE AltName: Full=Cytolysin IIIB;
DE Short=CLY-IIIB;
DE AltName: Full=RTX-III toxin determinant B;
GN Name=apxIIIB; Synonyms=clyIIIB, rtxB;
OS Actinobacillus pleuropneumoniae (Haemophilus pleuropneumoniae).
OC Bacteria; Proteobacteria; Gammaproteobacteria; Pasteurellales;
OC Pasteurellaceae; Actinobacillus.
OX NCBI_TaxID=715;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=Serotype 2;
RX PubMed=8494611; DOI=10.1089/dna.1993.12.351;
RA Chang Y.-F., Shi J., Ma D.-P., Shin S.J., Lein D.H.;
RT "Molecular analysis of the Actinobacillus pleuropneumoniae RTX toxin-III
RT gene cluster.";
RL DNA Cell Biol. 12:351-362(1993).
RN [2]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=405 / Serotype 8;
RX PubMed=7927703; DOI=10.1128/iai.62.10.4411-4418.1994;
RA Jansen R., Briaire J., van Geel A.B.M., Kamp E.M., Gielkens A.L.J.,
RA Smits M.A.;
RT "Genetic map of the Actinobacillus pleuropneumoniae RTX-toxin (Apx)
RT operons: characterization of the ApxIII operons.";
RL Infect. Immun. 62:4411-4418(1994).
RN [3]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-39.
RC STRAIN=405 / Serotype 8;
RX PubMed=8432615; DOI=10.1128/iai.61.3.947-954.1993;
RA Jansen R., Briaire J., Kamp E.M., Gielkens A.L.J., Smits M.A.;
RT "Cloning and characterization of the Actinobacillus pleuropneumoniae-RTX-
RT toxin III (ApxIII) gene.";
RL Infect. Immun. 61:947-954(1993).
CC -!- FUNCTION: Involved in the transport of the toxin RTX-III.
CC -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC -!- MISCELLANEOUS: The sequence shown is that of serotype 2.
CC -!- SIMILARITY: Belongs to the ABC transporter superfamily. Protein-1
CC exporter (TC 3.A.1.109) family. {ECO:0000305}.
CC -!- CAUTION: Tyr-13 is present instead of the conserved Cys which is
CC expected to be the active site residue of peptidase C39. Thus they are
CC presumed to be without peptidase activity. {ECO:0000305}.
CC -!- SEQUENCE CAUTION:
CC Sequence=CAA48712.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; L12145; AAA21925.1; -; Genomic_DNA.
DR EMBL; X80055; CAA56359.1; -; Genomic_DNA.
DR EMBL; X68815; CAA48712.1; ALT_INIT; Genomic_DNA.
DR PIR; S51785; C49219.
DR AlphaFoldDB; Q04473; -.
DR SMR; Q04473; -.
DR GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR GO; GO:0030256; C:type I protein secretion system complex; IEA:InterPro.
DR GO; GO:0140359; F:ABC-type transporter activity; IEA:InterPro.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR GO; GO:0008233; F:peptidase activity; IEA:InterPro.
DR GO; GO:0019835; P:cytolysis; IEA:UniProtKB-KW.
DR GO; GO:0030253; P:protein secretion by the type I secretion system; IEA:InterPro.
DR GO; GO:0006508; P:proteolysis; IEA:InterPro.
DR CDD; cd02417; Peptidase_C39_likeA; 1.
DR Gene3D; 1.20.1560.10; -; 1.
DR Gene3D; 3.40.50.300; -; 1.
DR InterPro; IPR003593; AAA+_ATPase.
DR InterPro; IPR011527; ABC1_TM_dom.
DR InterPro; IPR036640; ABC1_TM_sf.
DR InterPro; IPR003439; ABC_transporter-like_ATP-bd.
DR InterPro; IPR017871; ABC_transporter-like_CS.
DR InterPro; IPR010132; ATPase_T1SS_HlyB.
DR InterPro; IPR027417; P-loop_NTPase.
DR InterPro; IPR005074; Peptidase_C39.
DR InterPro; IPR039395; Peptidase_C39-like_A.
DR InterPro; IPR039421; Type_1_exporter.
DR PANTHER; PTHR24221; PTHR24221; 1.
DR Pfam; PF00664; ABC_membrane; 1.
DR Pfam; PF00005; ABC_tran; 1.
DR Pfam; PF03412; Peptidase_C39; 1.
DR SMART; SM00382; AAA; 1.
DR SUPFAM; SSF52540; SSF52540; 1.
DR SUPFAM; SSF90123; SSF90123; 1.
DR TIGRFAMs; TIGR01846; type_I_sec_HlyB; 1.
DR PROSITE; PS50929; ABC_TM1F; 1.
DR PROSITE; PS00211; ABC_TRANSPORTER_1; 1.
DR PROSITE; PS50893; ABC_TRANSPORTER_2; 1.
DR PROSITE; PS50990; PEPTIDASE_C39; 1.
PE 3: Inferred from homology;
KW ATP-binding; Cell membrane; Cytolysis; Membrane; Nucleotide-binding;
KW Transmembrane; Transmembrane helix; Transport.
FT CHAIN 1..711
FT /note="Toxin RTX-III translocation ATP-binding protein"
FT /id="PRO_0000092391"
FT TRANSMEM 162..182
FT /note="Helical"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT TRANSMEM 195..215
FT /note="Helical"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT TRANSMEM 273..293
FT /note="Helical"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT TRANSMEM 299..319
FT /note="Helical"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT TRANSMEM 392..412
FT /note="Helical"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT DOMAIN 1..129
FT /note="Peptidase C39"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00362"
FT DOMAIN 158..440
FT /note="ABC transmembrane type-1"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT DOMAIN 472..707
FT /note="ABC transporter"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00362,
FT ECO:0000255|PROSITE-ProRule:PRU00434"
FT ACT_SITE 87
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00362"
FT BINDING 506..513
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00362,
FT ECO:0000255|PROSITE-ProRule:PRU00434"
FT VARIANT 61
FT /note="M -> A (in serotype 8)"
FT VARIANT 91
FT /note="M -> T (in serotype 8)"
FT VARIANT 125..126
FT /note="GM -> DV (in serotype 8)"
FT VARIANT 213
FT /note="S -> N (in serotype 8)"
FT VARIANT 416
FT /note="T -> A (in serotype 8)"
FT VARIANT 469
FT /note="F -> K (in serotype 8)"
FT VARIANT 606
FT /note="L -> Q (in serotype 8)"
FT VARIANT 638
FT /note="S -> R (in serotype 8)"
SQ SEQUENCE 711 AA; 80406 MW; 5B8E46B889D12D92 CRC64;
MESQMPFNEK IDYGLHALVI LAQYHNVAVN PEEVKHKFDL DGKGLDLVAW LLAAKSLELK
MKRVKKSIER LPFIHLPALI WRDDGQHVIL MKIDTQTNRY LIFDLEERNP KVLSAAEFHE
IFQGGMILIT SRASIMGQLA KFDFTWFIPA VIKYRKIFVE TIIVSIFLQL FALITPLFFQ
VVMDKVLVHR GFSTLNVITV ALSVVVIFEI VLSGLRTYIF SHSTSRIDVE LGAKLFRHLL
ALPISYFENR RVGDTVARVR ELDQIRNFLT GQALTSVLDL LFSFIFFAVM WYYSPKLTIV
ILLSLPCYIA WSIFISPILR RRLDEKFARN ADNQSFLVES VSAIDTIKAL AVTPQMTNIW
DKQLASYVSA DFRVTVLATI GQQGVQLIQK TVMIINLWLG AHLVISGDLS IGQLITFNML
SGQVIAPVVR LAQLWQDFQQ VGISITRLGD VLNSPTENYQ GKLSLPEIFG DIAFKHIRFR
YKPDAPIILD DVNLSVKQGE VIGIVGRSGS GKSTLTKLLQ RFYIPENGQV LIDGHDLALA
DPNWLRRQIG VVLQDNVLLN RSIRDNIALT DPSMSMERVI YAAKLAGAHD FISELREGYN
TIVGELGAGL SGGQRQRIAI ARALVNNPRI LIFDEATSAL DYESEHIIMQ NMQKICHGRT
VIIIAHRLST VKNADRIIVM EKGHIVEQGK HNQLLENENG LYYYLNQLQS N